on 18 Aug 2020
Last Applicant/ Owned by
3525 N Regal St
Spokane
WA
99207
Serial Number
88521994 filed on 18th Jul 2019
Registration Number
6127746 registered on 18th Aug 2020
Correspondent Address
Laura M. Kelley
Filing Basis
1. use application currently
Disclaimer
NO DATA
Pharmaceutical preparations, namely, allergenic extracts for treating symptoms of allergies and allergenic extracts for allergy skin tests Medical consulting services in the field of allergy diagnosis and treatment Medical diagnostic apparatus, namely, percutaneous testing device; medical diagnostic test for allergies in the nature of percutaneous testing device; skin-testing device for allergie Read More
Pharmaceutical preparations, namely, allergenic extracts for treating symptoms of allergies and allergenic extracts for allergy skin tests
01st Jan 2012
01st Jan 2012
Medical diagnostic apparatus, namely, percutaneous testing device; medical diagnostic test for allergies in the nature of percutaneous testing device; skin-testing device for allergies, namely, percutaneous prick or scratch device for application to the skin for determining allergic reactions; device for application of allergenic extract skin tests, namely, percutaneous prick or scratch device for application to the skin for determining allergic reactions
01st Jan 2012
01st Jan 2012
Medical consulting services in the field of allergy diagnosis and treatment
01st Jan 2012
01st Jan 2012
No 88521994
No Service Mark
No 9774-26
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
18th Aug 2020 | REGISTERED-PRINCIPAL REGISTER |
02th Jun 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
02th Jun 2020 | PUBLISHED FOR OPPOSITION |
13th May 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
28th Apr 2020 | ASSIGNED TO LIE |
22nd Apr 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
20th Apr 2020 | TEAS VOLUNTARY AMENDMENT RECEIVED |
20th Apr 2020 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
09th Apr 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
09th Apr 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |